PANTOPRAZOLE SODIUM
Generic: PANTOPRAZOLE SODIUM
PANTOPRAZOLE SODIUM is FDA application NDA209463, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
CGMP Deviations
Failed Impurity/Degradation Specifications
Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance.
Presence of Particulate Matter: One vial from a lot of Pantoprazole Sodium for Injection (40 mg) con
CGMP deviations: tablets cracking
Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.
CGMP Deviations: Discoloration
Discoloration
Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than norma
CGMP Deviations: Intermittent exposure to temperature excursion during storage.